Abstract
The CORAL software (http://www.insilico.eu/coral) has been used to develop quantitative feature–property/activity relationships (QFPRs/QFARs) for the prediction of endpoints related to different categories of nanomaterials. In contrast to previous models built up by using CORAL from a representation of the molecular structure by using simplified molecular input-line entry system (SMILES), the current QFPR/QFARs are based on an integrated representation of acting conditions (i.e., a combination of physicochemical and/or biochemical factors) of nanomaterials via the so-called quasi-SMILES notation. In contrast to traditional quantitative structure – property / activity relationships (QSPRs/QSARs), the new models are able to provide new insight on the conditions of acting of substances (e.g., chemicals and nanomaterials) independently of their molecular structure. The development and validation of the QFPR/QFAR models was carried out following the OECD principles. The statistical quality of models developed from quasi-SMILES is acceptable, with values for the determination coefficient in the range of 0.70 to 0.85 for various endpoints of environmental and human health relevance. Perspectives of the QFPR/QFAR and their interaction and overlapping with traditional QSPR/QSAR are also discussed.
Keywords: Monte Carlo method, Nanomaterial, QFPR/QFAR, QSPR/QSAR, Quasi-SMILES.
Graphical Abstract
Current Topics in Medicinal Chemistry
Title:Use of Quasi-SMILES and Monte Carlo Optimization to Develop Quantitative Feature Property/Activity Relationships (QFPR/QFAR) for Nanomaterials
Volume: 15 Issue: 18
Author(s): Andrey A. Toropov, Robert Rallo and Alla P. Toropova
Affiliation:
Keywords: Monte Carlo method, Nanomaterial, QFPR/QFAR, QSPR/QSAR, Quasi-SMILES.
Abstract: The CORAL software (http://www.insilico.eu/coral) has been used to develop quantitative feature–property/activity relationships (QFPRs/QFARs) for the prediction of endpoints related to different categories of nanomaterials. In contrast to previous models built up by using CORAL from a representation of the molecular structure by using simplified molecular input-line entry system (SMILES), the current QFPR/QFARs are based on an integrated representation of acting conditions (i.e., a combination of physicochemical and/or biochemical factors) of nanomaterials via the so-called quasi-SMILES notation. In contrast to traditional quantitative structure – property / activity relationships (QSPRs/QSARs), the new models are able to provide new insight on the conditions of acting of substances (e.g., chemicals and nanomaterials) independently of their molecular structure. The development and validation of the QFPR/QFAR models was carried out following the OECD principles. The statistical quality of models developed from quasi-SMILES is acceptable, with values for the determination coefficient in the range of 0.70 to 0.85 for various endpoints of environmental and human health relevance. Perspectives of the QFPR/QFAR and their interaction and overlapping with traditional QSPR/QSAR are also discussed.
Export Options
About this article
Cite this article as:
Toropov A. Andrey, Rallo Robert and Toropova P. Alla, Use of Quasi-SMILES and Monte Carlo Optimization to Develop Quantitative Feature Property/Activity Relationships (QFPR/QFAR) for Nanomaterials, Current Topics in Medicinal Chemistry 2015; 15 (18) . https://dx.doi.org/10.2174/1568026615666150506152000
DOI https://dx.doi.org/10.2174/1568026615666150506152000 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
Call for Papers in Thematic Issues
Medicinal Chemistry Advancement in Life-Threatening Diseases
The current issue will highlight concise reports that specify ground-breaking insights, including the novel discovery of drug targets and their action mechanism or drugs of novel classes. These are projected to encourage medicinal chemistry future efforts to address the most challenging medical needs. The current issue highlights further efforts to ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
ADAM19/Adamalysin 19 Structure, Function, and Role as a Putative Target in Tumors and Inflammatory Diseases
Current Pharmaceutical Design Cellular and Physiological Effects of Probiotics and Prebiotics
Mini-Reviews in Medicinal Chemistry Studies on the Pathophysiology and Genetic Basis of Migraine
Current Genomics Tubulin-Targeting Agents in Hybrid Drugs
Current Medicinal Chemistry Synthesis and Biological Evaluation of Novel N' (4-aryloxybenzylidene)- 1H-Benzimidazole-2 Carbohydrazide Derivatives as Anti-Tubercular Agents
Combinatorial Chemistry & High Throughput Screening Should the Incorporation of Structural Alerts be Restricted in Drug Design? An Analysis of Structure-Toxicity Trends with Aniline-Based Drugs
Current Medicinal Chemistry Patients Characteristics and Clinical Implications of Suboptimal CD4 T-Cell Gains After 1 Year of Successful Antiretroviral Therapy
Current HIV Research Recent Achievements on Siderophore Production and Application
Recent Patents on Biotechnology The Role of B-Lymphocyte Stimulator in Neuroendocrine Tumors: Correlation with Tumor Differentiation, Disease status and the Presence of Metastases
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Intestinal Immunomodulation. Role of Regulative Peptides and Promising Pharmacological Activities
Current Pharmaceutical Design Extending the Clinical Horizons of Mucosal Bacterial Vaccines: Current Evidence and Future Prospects
Current Drug Targets Anticancer Lignans - from Discovery to Biotechnology
Mini-Reviews in Medicinal Chemistry Anticancer Agents: Tumor Cell Growth Inhibitory Activity and Binary QSAR Analysis
Current Pharmaceutical Design A Comprehensive Review on Pharmacognostical Investigation and Pharmacology of Typhonium trilobatum
The Natural Products Journal Vitamin E and All-Cause Mortality: A Meta-Analysis
Current Aging Science Current Treatment Options for HCC: From Pharmacokinetics to Efficacy and Adverse Events in Liver Cirrhosis
Current Drug Metabolism Prediction of MHC-Peptide Binding: A Systematic and Comprehensive Overview
Current Pharmaceutical Design An Update of the Classical and Novel Methods Used for Measuring Fast Neurotransmitters During Normal and Brain Altered Function
Current Neuropharmacology Gut Emotions - Mechanisms of Action of Probiotics as Novel Therapeutic Targets for Depression and Anxiety Disorders
CNS & Neurological Disorders - Drug Targets Factors Affecting the Metabolite Productions in Endophytes: Biotechnological Approaches for Production of Metabolites
Current Medicinal Chemistry